Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial

CONCLUSIONS: In rigorously defined pre-NAC cN1 breast cancer patients, standard TAD is feasible for those with negative axillary palpation after NAC, and FNR is also less than 10%.REGISTRATION: chictr.org.cn, ChiCTR2100049093.PMID:38557731 | DOI:10.1097/CM9.0000000000003007

Source: Chinese Medical Journal - April 1, 2024 Category: General Medicine Authors: Xiuchun Chen Zhenduo Lu Chengzheng Wang Minhao Lyu Jianghua Qiao Xianfu Sun Lianfang Li Chongjian Zhang Zhenzhen Liu Source Type: research